Abstract:In 1995, the macrophage–T lymphocyte theory of schizophrenia (Smith and Maes, 1995) considered that activated immuno‐inflammatory pathways may account for the higher neurodevelopmental pathology linked with gestational infections through the detrimental effects of activated microglia, oxidative and nitrosative stress (O&NS), cytokine‐induced activation of the tryptophan catabolite (TRYCAT) pathway and consequent modulation of the N‐methyl d‐aspartate receptor (NMDAr) and glutamate production. The aim of the present paper is to review the current state‐of‐the art regarding the role of the above pathways in schizophrenia. Accumulating data suggest a powerful role for prenatal infection, both viral and microbial, in driving an early developmental etiology to schizophrenia. Models of prenatal rodent infection show maintained activation of immuno‐inflammatory pathways coupled to increased microglia activation. The ensuing activation of immuno‐inflammatory pathways in schizophrenia may activate the TRYCAT pathway, including increased kynurenic acid (KA) and neurotoxic TRYCATs. Increased KA, via the inhibition of the α7 nicotinic acetylcholine receptor, lowers gamma‐amino‐butyric‐acid (GABA)ergic post‐synaptic current, contributing to dysregulated glutamatergic activity. Hypofunctioning of the NMDAr on GABAergic interneurons will contribute to glutamatergic dysregulation. Many susceptibility genes for schizophrenia are predominantly expressed in early development and will interact with these early developmental driven changes in the immuno‐inflammatory and TRYCAT pathways. Maternal infection and subsequent immuno‐inflammatory responses are additionally associated with O&NS, including lowered antioxidants such as glutathione. This will contribute to alterations in neurogenesis and myelination. In such a scenario a) a genetic or epigenetic potentiation of immuno‐inflammatory pathways may constitute a double hit on their own, stimulating wider immuno‐inflammatory responses and thus potentiating the TRYCAT pathway and subsequent NMDAr dysfunction and neuroprogression; and b) antipsychotic‐induced changes in immuno‐inflammatory, TRYCAT and O&NS pathways would modulate the CNS glia‐neuronal interactions that determine synaptic plasticity as well as myelin generation and maintenance.

A new schizophrenia model: immune activation is associated with induction of the tryptophan catabolite pathway and increased eotaxin levels which together determine memory impairments and schizophrenia symptom dimensions.

A new schizophrenia model: immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions.

In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study

Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia

In Schizophrenia, Psychomotor Retardation is Associated with Executive and Memory Impairments, Negative and Psychotic Symptoms, Neurotoxic Immune Products and Lower Natural IgM to Malondialdehyde

Supervised Machine Learning to Decipher the Complex Associations Between Neuro-Immune Biomarkers and Quality of Life in Schizophrenia

The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study

Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.

The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia Are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.

Schizophrenia Phenomenology Comprises a Bifactorial General Severity and a Single-Group Factor, Which Are Differently Associated with Neurotoxic Immune and Immune-Regulatory Pathways.

Deficit Schizophrenia is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (trycats): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation

Temporal Changes in Brain Morphology Related to Inflammation and Schizophrenia: an Omnigenic Mendelian Randomization Study.

Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.

In Schizophrenia, Immune-Inflammatory Pathways Are Strongly Associated with Depressive and Anxiety Symptoms, Which Are Part of a Latent Trait Which Comprises Neurocognitive Impairments and Schizophrenia Symptoms.

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways.

Frontostriatal Circuitry and the Tryptophan Kynurenine Pathway in Major Psychiatric Disorders

High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations with Interleukin-6, Symptom Domains, and Neurocognitive Impairments

Physio-Somatic Symptoms in Schizophrenia: Association with Depression, Anxiety, Neurocognitive Deficits and the Tryptophan Catabolite Pathway

In Schizophrenia, Low Natural IgM Antibody Titers to Oxidative Specific Epitopes and Higher IgM Responses to Nitrated and Nitrosylated Proteins Strongly Predict Negative Symptoms, Neurocognitive Impairments and the Deficit Syndrome

Effects of Neuroactive Metabolites of the Tryptophan Pathway on Working Memory and Cortical Thickness in Schizophrenia.

Association of Elevated Levels of Peripheral Complement Components with Cortical Thinning and Impaired Logical Memory in Drug-Naïve Patients with First-Episode Schizophrenia